Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus

Lupus

Volumn 24, Issue 2, 2015, Pages 155-163

  Sabio, J M ^a   Vargas Hitos, J A ^a   Martinez Bordonado, J ^a   Navarrete Navarrete, N ^a   Diaz Chamorro A ^a   Olvera Porcel, C ^b   Zamora, M ^a   Jimenez Alonso J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b Department of Statistics   (Spain)

Author keywords

arterial stiffness; insulin resistance; metabolic syndrome; pulse wave velocity; systemic lupus erythematosus; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; FIBRINOGEN; GLUCOSE; HOMOCYSTEINE; HYDROXYCHLOROQUINE; INSULIN; LIPID; PREDNISONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERIAL STIFFNESS; ARTICLE; BLOOD SAMPLING; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HUMAN; INSULIN RESISTANCE; INSULINEMIA; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PULSE WAVE; SEASONAL VARIATION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION; AGE; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; VITAMIN D DEFICIENCY;

ADULT; AGE FACTORS; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; INSULIN; INSULIN RESISTANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84921513513     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314551811     Document Type: Article

References (42)

1. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol. 1997 ; 145: 408-415
2. Skaggs BJ, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE: Mechanisms and management. Nat Rev Rheumatol. 2012 ; 8: 214-223
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 ; 357: 266-281
4. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006 ; 37: 243-245
5. Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: Population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012 ; 32: 2794-2802
6. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007 ; 167: 1159-1165
7. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1.25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 ; 168: 1340-1349
8. García-Bailo B, Da Costa LA, Arora P, Karmali M, El-Sohemy A, Badawi A. Plasmavitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009. Prev Chronic Dis. 2013 ; 10: E91 - E91
9. Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010 ; 33: 1379-1381
10. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005 ; 28: 1228-1230
11. Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008 ; 10: 273-280
12. Sakthiswary R, Raymond AA. The clinical significance of vitamin D in systemic lupus erythematosus. PLoS One. 2013 ; 8: e55275 - e55275
13. Kiani AN, Fang H, Magder LS, Petri M. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology. 2013 ; 52: 2071-2076
14. Ravenell RL, Kamen DL, Spence JD, et al. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci. 2012 ; 344: 268-273
15. Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012 ; 51: 544-551
16. Wu PW, Rhew EY, Dyer AR, et al. 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 1387-1395
17. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: Relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford). 2012 ; 51: 644-652
18. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study. Diabetes Care. 2002 ; 25: 1177-1184
19. El Magadmi M, Ahmad Y, Turkie W, et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol. 2006 ; 33: 50-56
20. Posadas-Romero C, Torres-Tamayo M, Zamora-González J, et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum. 2004 ; 50: 160-165
21. Sabio JM, Zamora-Pasadas M, Jiménez-Jáimez J, et al. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus. 2008 ; 17: 849-859
22. Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, et al. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 2204-2211
23. Mok CC, Poon WL, Lai JP, et al. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. Scand J Rheumatol. 2010 ; 39: 42-49
24. Tso TK, Huang WN, Huang HY, Chang CK. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006 ; 45: 1148-1153
25. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol. 2010 ; 55: 1318-1327
26. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 ; 112: 2735-2752
27. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
28. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
29. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995 ; 26: 485-490
30. Chung CP, Oeser A, Solus JF, et al. Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008 ; 58: 2105-2112
31. Sabio JM, Vargas-Hitos JA, Navarrete N, Hidalgo-Tenorio C, Jiménez-Alonso J. Effects of low or medium-dose of prednisone on insulin resistance in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2010 ; 28: 483-489
32. Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum. 2005 ; 52: 3651-3659
33. Mezza T, Muscogiuri G, Sorice GP, et al. Vitamin D deficiency: A new risk factor for type 2 diabetes?. Ann Nutr Metab. 2012 ; 61: 337-348
34. Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010 ; 33: 2021-2023
35. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003 ; 88: 157-161
36. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000 ; 72: 690-693
37. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981 ; 34: 2359-2363
38. Muscogiuri G, Sorice GP, Prioletta A, et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring). 2010 ; 18: 1906-1910
39. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: Data from a single centre registry in Hungary. Scand J Rheumatol. 2011 ; 40: 122-126
40. Shoben AB, Kestenbaum B, Levin G, et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. Am J Epidemiol. 2011 ; 174: 1363-1372
41. Hamza RT, Awwad KS, Ali MK, Hamed AI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: Relation to disease activity. Med Sci Monit. 2011 ; 17: CR711 - CR718
42. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis. 2010 ; 69: 1155-1157